acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule

RxCUI
2049223
RxNorm name
acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule
Display name
Acetaminophen/guaiFENesin/Phenylephrine (Oral Pill)
Full name
acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule
Term type
SCD
Status
Active
Strength
325-200-5 mg
Dose form
Cap
Route
Oral Pill
Updated
2026-11-08 10:05:25

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
082018
Active start
082018
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
acetaminophen325 MG / 1 EACHacetaminophenacetaminophen
guaifenesin200 MG / 1 EACHguaifenesinguaifenesin
phenylephrine hydrochloride5 MG / 1 EACHphenylephrinephenylephrine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Capsule316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
acetaminophen161
guaifenesin5032
phenylephrine8163

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
37000-951-2437000-951Vicks Sinex Severe Acetaminophen, Phenylephrine HCl, GuaifenesinThe Procter & Gamble Manufacturing CompanyM012
82706-020-0182706-020AXIV Sinus Severe Mucus Acetaminophen, Guaifenesin, Phenylephrine HydroclorideVIVUNT PHARMA LLCM012
82706-020-0382706-020AXIV Sinus Severe Mucus Acetaminophen, Guaifenesin, Phenylephrine HydroclorideVIVUNT PHARMA LLCM012
82706-020-0482706-020AXIV Sinus Severe Mucus Acetaminophen, Guaifenesin, Phenylephrine HydroclorideVIVUNT PHARMA LLCM012

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01237000-951Vicks Sinex Severe Acetaminophen, Phenylephrine HCl, GuaifenesinOTC MONOGRAPH DRUGThe Procter & Gamble Manufacturing Company

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 9 matching rows.

NDC11, Source, Active table
NDC11SourceActive
23900003958rxnav_ndcsyes
37000095124rxnav_ndcsyes
82706002001rxnav_ndcsyes
82706002002rxnav_ndcsyes
82706002003rxnav_ndcsyes
82706002004rxnav_ndcsyes
37000052524rxnav_historical
82706000601rxnav_historical
82706000602rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Vicks Sinex Severe All in One Sinus MucusACETAMINOPHEN, PHENYLEPHRINE HCL, GUAIFENESINThe Procter & Gamble Manufacturing Company9a106291-edda-2135-e053-2995a90a44fd2026-10-02WarningsExact identifier
ndc (package): 37000-951-24
ndc (product): 37000-951
ndc11 (package): 37000095124
rxcui: 2049223
AXIV Sinus Severe MucusACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCLORIDEVIVUNT PHARMA LLC13245298-8b78-e177-e063-6294a90a6bec2025-09-17WarningsExact identifier
ndc (package): 82706-020-01
ndc (package): 82706-020-04
ndc (package): 82706-020-03
ndc (product): 82706-020
ndc11 (package): 82706002001
ndc11 (package): 82706002003
ndc11 (package): 82706002002
ndc11 (package): 82706002004
rxcui: 2049223

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9a106291-edda-2135-e053-2995a90a44fdacetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Capsule [PSN] · acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule [SCD] · APAP 325 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule [SY]311VICKS ® Sinex ™ Severe All in One Sinus + Mucus LiquiCaps20251112
13245298-8b78-e177-e063-6294a90a6becacetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Capsule [PSN] · acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule [SCD] · APAP 325 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule [SY]36AXIV - Sinus Severe + Mucus20250917

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
9a106291-edda-2135-e053-2995a90a44fdVICKS ® Sinex ™ Severe All in One Sinus + Mucus LiquiCapsThe Procter & Gamble Manufacturing Company20261002
9a106291-edda-2135-e053-2995a90a44fdVICKS ® Sinex ™ Severe All in One Sinus + Mucus LiquiCapsThe Procter & Gamble Manufacturing Company20251112
13245298-8b78-e177-e063-6294a90a6becAXIV - Sinus Severe + MucusVIVUNT PHARMA LLC20250917
9a106291-edda-2135-e053-2995a90a44fdVICKS ® Sinex ™ Severe All in One Sinus + Mucus LiquiCapsThe Procter & Gamble Manufacturing Company20250806
de9eb2d5-ba54-4637-e053-2995a90a0451AXIM - Sinus Severe + MucusVIVUNT PHARMA LLC20240614
6f1662e7-5e3b-938d-e053-2991aa0abca4VICKS ® Sinex ™ Severe Congestion LiquiCaps LiquiCapsThe Procter & Gamble Manufacturing Company20191219

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC01CAAdrenergic and dopaminergic agentsATC1-4phenylephrine
ATCN02BEAnilidesATC1-4acetaminophen
ATCR05CAExpectorantsATC1-4guaifenesin
ATCC05AXOther agents for treatment of hemorrhoids and anal fissures for topical useATC1-4phenylephrine
ATCR01BASympathomimeticsATC1-4phenylephrine
ATCS01FBSympathomimetics excl. antiglaucoma preparationsATC1-4phenylephrine
ATCS01GASympathomimetics used as decongestantsATC1-4phenylephrine
ATCR01ABSympathomimetics, combinations excl. corticosteroidsATC1-4phenylephrine
ATCR01AASympathomimetics, plainATC1-4phenylephrine
FDASPLN0000186105alpha-1 Adrenergic AgonistEPChas_epcphenylephrine
FDASPLN0000193956ExpectorantEPChas_epcguaifenesin
MEDRTD000082AcetaminophenCHEMhas_ingredientacetaminophen
MEDRTD006140GuaifenesinCHEMhas_ingredientguaifenesin
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine hydrochloride
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine hydrochloride
MEDRTD001991BronchitisDISEASEmay_treatguaifenesin
MEDRTD003139Common ColdDISEASEmay_treatguaifenesin
MEDRTD003371CoughDISEASEmay_treatguaifenesin
MEDRTD004342Drug HypersensitivityDISEASEci_withacetaminophen
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine
MEDRTD004342Drug HypersensitivityDISEASEci_withguaifenesin
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine hydrochloride
MEDRTD005334FeverDISEASEmay_treatacetaminophen
MEDRTD005334FeverDISEASEmay_preventacetaminophen
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine hydrochloride
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine hydrochloride
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine
MEDRTD005955Glucosephosphate Dehydrogenase DeficiencyDISEASEci_withacetaminophen
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine hydrochloride
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine
MEDRTD006973HypertensionDISEASEci_withphenylephrine hydrochloride
MEDRTD006973HypertensionDISEASEci_withphenylephrine
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine hydrochloride
MEDRTD007827LaryngitisDISEASEmay_treatguaifenesin
MEDRTD008107Liver DiseasesDISEASEci_withacetaminophen
MEDRTD015878MydriasisDISEASEinducesphenylephrine hydrochloride
MEDRTD015878MydriasisDISEASEinducesphenylephrine
MEDRTD010146PainDISEASEmay_preventacetaminophen
MEDRTD010146PainDISEASEmay_treatacetaminophen
MEDRTD010612PharyngitisDISEASEmay_treatguaifenesin
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine hydrochloride
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatguaifenesin
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine
MEDRTD012852SinusitisDISEASEmay_treatguaifenesin
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine hydrochloride
MEDRTD014917Whooping CoughDISEASEmay_treatguaifenesin
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine hydrochloride
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moaacetaminophen
MEDRTN0000175724Central Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine hydrochloride
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine hydrochloride
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peacetaminophen
MEDRTN0000008867Decreased Respiratory Secretion ViscosityPEhas_peguaifenesin
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_peacetaminophen
MEDRTN0000009560Increased Respiratory SecretionsPEhas_peguaifenesin
MEDRTN0000175725Peripheral Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkacetaminophen
MEDRTN0000000042Renal ExcretionPKhas_pkacetaminophen

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH325 MG / 200 MG / 5 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymacetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Capsule
NAMESTallman Synonymacetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule
NAMESTallman SynonymAPAP 325 MG / guaiFENesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels